Healthcare provider profile · identity verified

Jessie Sumner, PA-C

Physician Assistant · MADERA, CA · NPI 1346351764

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	287	104
Lisinopril	Lisinopril	287	85
Metformin Hcl	Metformin Hcl	243	74
Levothyroxine Sodium	Levothyroxine Sodium	216	58
Albuterol Sulfate Hfa	Albuterol Sulfate	192	62
Amlodipine Besylate	Amlodipine Besylate	185	64
Gabapentin	Gabapentin	179	48
Hydrochlorothiazide	Hydrochlorothiazide	165	58
Losartan Potassium	Losartan Potassium	159	53
Tramadol Hcl	Tramadol Hcl	148	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	133	17
Omeprazole	Omeprazole	110	35
Hydroxyzine Hcl	Hydroxyzine Hcl	107	28
Alendronate Sodium	Alendronate Sodium	104	28
Enalapril Maleate	Enalapril Maleate	99	29
Metoprolol Succinate	Metoprolol Succinate	97	30
Glipizide	Glipizide	94	25
Ozempic	Semaglutide	93	18
Montelukast Sodium	Montelukast Sodium	87	25
Sertraline Hcl	Sertraline Hcl	81	24
Simvastatin	Simvastatin	80	25
Famotidine	Famotidine	76	27
Nabumetone	Nabumetone	74	23
Tamsulosin Hcl	Tamsulosin Hcl	72	23
Buspirone Hcl	Buspirone Hcl	68	13
Pravastatin Sodium	Pravastatin Sodium	66	20
Ibuprofen	Ibuprofen	61	19
Jardiance	Empagliflozin	59	16
Fluticasone Propionate	Fluticasone Propionate	58	26
Pioglitazone Hcl	Pioglitazone Hcl	54	15
Pregabalin	Pregabalin	54	suppressed
Meloxicam	Meloxicam	51	16
Furosemide	Furosemide	47	15
Carvedilol	Carvedilol	46	12
Triamcinolone Acetonide	Triamcinolone Acetonide	46	27
Dicyclomine Hcl	Dicyclomine Hcl	45	suppressed
Januvia	Sitagliptin Phosphate	45	12
Hydralazine Hcl	Hydralazine Hcl	44	11
Eliquis	Apixaban	43	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	41	13
Diclofenac Sodium	Diclofenac Sodium	40	19
Azelastine Hcl	Azelastine Hcl	37	18
Pantoprazole Sodium	Pantoprazole Sodium	36	11
Chlorthalidone	Chlorthalidone	35	11
Ondansetron Odt	Ondansetron	35	17
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Trulicity	Dulaglutide	35	suppressed
Ventolin Hfa	Albuterol Sulfate	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	11
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Trazodone Hcl	Trazodone Hcl	28	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	suppressed
Atenolol	Atenolol	25	suppressed
Ketoconazole	Ketoconazole	25	12
Lactulose	Lactulose	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Gemfibrozil	Gemfibrozil	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Sucralfate	Sucralfate	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Diazepam	Diazepam	22	suppressed
Dutasteride	Dutasteride	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Naproxen	Naproxen	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Icosapent Ethyl	Icosapent Ethyl	18	suppressed
Pulmicort Flexhaler	Budesonide	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Duloxetine Hcl	Duloxetine Hcl	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Prempro	Estrogen,con/M-Progest Acet	17	suppressed
Azithromycin	Azithromycin	16	15
Carbamazepine	Carbamazepine	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Vascepa	Icosapent Ethyl	16	suppressed
Baclofen	Baclofen	15	suppressed
Colestipol Hcl	Colestipol Hcl	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	15	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	14	suppressed
Linzess	Linaclotide	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Valsartan	Valsartan	14	suppressed
Amoxicillin	Amoxicillin	13	12
Bupropion Xl	Bupropion Hcl	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Alprazolam	Alprazolam	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Finasteride	Finasteride	11	suppressed
Methimazole	Methimazole	11	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Prednisone	Prednisone	11	suppressed
Zenpep	Lipase/Protease/Amylase	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error